Medical marketing system based on Taas platform
Through the medical marketing system based on the Taas platform, the problem that medical systems are difficult to overcome distance problems is solved, and the effect of improving the efficiency of medical resource utilization and data security is achieved.
Patent Information
- Application Number
- CN202510097547.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-01-22
- Publication Date
- 2025-05-23
AI Technical Summary
The existing medical system is difficult to overcome the distance problem, making it difficult for patients in remote areas to obtain timely and professional medical services.
The medical marketing system based on the Taas platform includes user-side display module, data acquisition module, data storage module, Taas platform and security protection module. Through technical means such as data analysis, personalized recommendation, traffic leasing services and data encryption, the utilization efficiency of medical resources and data security are improved.
It realizes a customized user interface, improves user satisfaction and system usage efficiency; through data analysis and personalized recommendation, improves the goal and conversion rate of marketing activities; data encryption and user authentication mechanisms ensure data security; the traffic leasing service of the TaaS platform helps pharmaceutical companies to allocate and utilize marketing resources more effectively.
Smart Images
Figure CN120031630A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of medical management platforms, and specifically refers to a medical marketing system based on a Taas platform. Background Art
[0002] Taas is the abbreviation of traffic-as-a-service. As the commercialization of traffic in the traditional sense of the Internet, it means monetization through traffic transactions. In this transaction scenario, traffic buyers use the traffic of traffic sellers for commercial purposes based on certain promotion demands.
[0003] The current medical system is not convenient for overcoming distance problems, and patients in remote areas often find it difficult to obtain timely and professional medical services. Summary of the invention
[0004] In view of the above situation, in order to overcome the defects of the prior art, the present invention provides a medical marketing system based on the Taas platform, which effectively solves the problems in the current market.
[0005] The technical solution adopted by the present invention is as follows: The present invention proposes a medical marketing system based on the Taas platform, comprising:
[0006] (1) User-side display module: provides customized interfaces for doctors, patients, and pharmaceutical companies;
[0007] (2) Data collection module: collects information about doctors, patients, and pharmaceutical companies, and divides each user group into different groups;
[0008] (3) Data storage module: collects and stores all kinds of information released by doctors, patients and pharmaceutical companies to form a database, and the contents in the database can be searched and consulted by doctors, patients and pharmaceutical company personnel according to their needs;
[0009] (4) Taas platform: provides traffic leasing services to pharmaceutical customers through the private traffic pool of doctors, while the user end is used by pharmaceutical customers to place orders, make payments, design questionnaires, upload brand promotions, and obtain survey results;
[0010] (5) Security protection module: Encrypts the information collected by the data acquisition module and the large amount of information stored in the data storage module to ensure data security and user privacy.
[0011] Furthermore, the user-side display module can also construct a detailed user portrait through data analysis and the information entered by itself.
[0012] Furthermore, the data acquisition module includes a data analysis engine, which uses big data and AI technology to perform in-depth analysis and can provide personalized recommendations to users based on the analysis results.
[0013] Furthermore, the personalized recommendation of the data collection module is screened by similarity calculation method, and the similarity calculation formula is Sim=f sim (UP, IP), where Sim in the formula is the similarity score, and f in the formula sim is a similarity calculation function, and the recommendation list generation can be expressed as RL = f rl (Sim,N), where RL in the formula is the recommendation list, f rl is the function that generates the recommendation list, and N is the number of recommended items.
[0014] Furthermore, the data storage module also includes data encryption and user authentication, and the formula for data encryption is Enc(Data)=f enc (Data,Key), where Enc(Data) is the encrypted data, f enc Is an encryption function that encrypts data using an encryption algorithm and a key.
[0015] Furthermore, the formula for decrypting data in the data storage module is Dec(Enc(Data))=f dec (Enc(Data),Key), where Dec(Enc(Data)) is the decrypted data, i.e. the original data, f dec is the decryption function, which uses the same algorithm and key as the encryption function to decrypt the data.
[0016] Furthermore, the formula for user authentication in the data storage module is Auth(User)=f auth (Credentials), where Auth(User) is a Boolean value indicating whether the user is authenticated. auth It is an authentication function that accepts the user's credentials (such as username and password, biometric data, etc.) as input. Credentials includes the user's identity information.
[0017] Furthermore, the user terminal display module includes information architecture design, interaction design and visual design. The formula used in the information architecture design is IAD=f iad (UR), where IAD is information architecture design, which defines the organization and navigation structure of the content, iad It is the information architecture design process.
[0018] Furthermore, the interactive design in the user terminal display module adopts ID=fid (IAD), where ID is interaction design, which defines the interaction between users and the system, and f id It is an interactive design process.
[0019] Furthermore, the visual design in the user terminal display module adopts VD=f vd (ID), where VD is visual design, including visual elements such as color, font, layout, etc. vd It is a visual design process.
[0020] The beneficial effects achieved by the present invention using the above structure are as follows:
[0021] The customized user interface will improve user satisfaction and system usage efficiency. Through the data analysis engine, doctors, patients and pharmaceutical companies will be able to make decisions based on more accurate data. The personalized recommendation system will improve the targeting and conversion rate of marketing activities. Data encryption and user authentication mechanisms will protect sensitive information from unauthorized access. The traffic leasing service of the TaaS platform will help pharmaceutical companies allocate and utilize marketing resources more effectively. The data storage module will promote the sharing of medical information among doctors, patients and pharmaceutical companies. The construction of user portraits will help service providers better understand user needs and provide more personalized services. Automated data collection and analysis will reduce manual operations and reduce operating costs. Through precise market positioning and user insights, pharmaceutical companies can improve their market competitiveness. Through effective brand promotion and user feedback collection, pharmaceutical companies can establish and maintain a positive brand image. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 This is a module diagram of a medical marketing system based on the Taas platform proposed by the present invention.
[0023] The accompanying drawings are used to provide further understanding of the present invention and constitute a part of the specification. They are used to explain the present invention together with the embodiments of the present invention and do not constitute a limitation of the present invention. DETAILED DESCRIPTION
[0024] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments; based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
[0025] In the description of the present invention, it is necessary to understand that terms such as “upper”, “lower”, “front”, “back”, “left”, “right”, “top”, “bottom”, “inside” and “outside” indicating directions or positional relationships are based on the directions or positional relationships shown in the accompanying drawings and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and therefore cannot be understood as limiting the present invention.
[0026] The present invention proposes a medical marketing system based on the Taas platform, comprising:
[0027] (1) User-side display module: provides customized interfaces for doctors, patients, and pharmaceutical companies;
[0028] (2) Data collection module: collects information about doctors, patients, and pharmaceutical companies, and divides each user group into different groups;
[0029] (3) Data storage module: collects and stores all kinds of information released by doctors, patients and pharmaceutical companies to form a database, and the contents in the database can be searched and consulted by doctors, patients and pharmaceutical company personnel according to their needs;
[0030] (4) Taas platform: provides traffic leasing services to pharmaceutical customers through the private traffic pool of doctors, while the user end is used by pharmaceutical customers to place orders, make payments, design questionnaires, upload brand promotions, and obtain survey results;
[0031] (5) Security protection module: Encrypts the information collected by the data acquisition module and the large amount of information stored in the data storage module to ensure data security and user privacy.
[0032] The user-side display module can also build a detailed user portrait through data analysis and the information it enters.
[0033] The data collection module includes a data analysis engine, which uses big data and AI technology to conduct in-depth analysis and can provide personalized recommendations for users based on the analysis results. The personalized recommendations of the data collection module are screened using the similarity calculation method. The similarity calculation formula is Sim = f sim (UP, IP), where Sim in the formula is the similarity score, and f in the formula sim is the similarity calculation function, and the recommendation list generation can be expressed as RL = f rl (Sim,N), where RL in the formula is the recommendation list, f rl is the function that generates the recommendation list, and N is the number of recommended items.
[0034] The data storage module also includes data encryption and user authentication. The data encryption formula is Enc(Data)=f enc (Data,Key), where Enc(Data) is the encrypted data, f enc It is an encryption function, which uses encryption algorithm and key to encrypt data. The formula for data decryption in the data storage module is Dec(Data)) = f dec (Enc(Data),Key), where Dec(Enc(Data)) is the decrypted data, i.e. the original data, f dec is the decryption function, which uses the same algorithm and key as the encryption function to decrypt the data.
[0035] The formula for user authentication in the data storage module is Auth(User) = f auth (Credentials), where Auth(User) is a Boolean value indicating whether the user is authenticated. auth It is an authentication function that accepts the user's credentials (such as username and password, biometric data, etc.) as input. Credentials includes the user's identity information.
[0036] The user-side display module includes information architecture design, interaction design and visual design. The formula used in information architecture design is IAD = f iad (UR), where IAD is information architecture design, which defines the organization and navigation structure of the content, iad It is the information architecture design process. The interactive design in the user-side display module adopts ID=f id (IAD), where ID is interaction design, which defines the interaction between users and the system, and f id It is an interactive design process. The visual design in the user-side display module adopts VD=f vd (ID), where VD is visual design, including visual elements such as color, font, layout, etc. vd It is a visual design process.
[0037] During specific use, the user interacts with the system through a customized interface. The system provides corresponding functions and services based on the user's role (doctor, patient, pharmaceutical company). The system collects user data and analyzes it through a data analysis engine to build a user portrait and provide personalized recommendations. User data is stored in a database and protected by data encryption and user authentication mechanisms. The TaaS platform manages traffic services and provides pharmaceutical companies with market research tools and brand promotion channels. The security protection module ensures the security of data transmission and storage to prevent unauthorized access. The design of the user-side display module, including information architecture, interaction and visual design, ensures the intuitiveness and ease of use of the user interface. The above is the overall workflow of the present invention. Just repeat this step next time you use it. The actual operation process is very simple and easy.
[0038] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.
[0039] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
[0040] The present invention and its embodiments are described above, and such description is not restrictive. The drawings show only one embodiment of the present invention, and the actual structure is not limited thereto. In short, if ordinary technicians in the field are inspired by it, without departing from the purpose of the invention, they can design a structure and embodiment similar to the technical solution without creativity, which should belong to the protection scope of the present invention.
Claims
1. A medical marketing system based on the Taas platform, characterized by: include: (1) User-side display module: provides customized interfaces for doctors, patients, and pharmaceutical companies; (2) Data collection module: collects information about doctors, patients, and pharmaceutical companies, and divides each user group into different categories; (3) Data storage module: collects and stores all kinds of information released by doctors, patients and pharmaceutical companies to form a database, and the contents in the database can be searched and consulted by doctors, patients and pharmaceutical company personnel according to their needs; (4) Taas platform: provides traffic leasing services to pharmaceutical customers through the private traffic pool of doctors, while the user end is used by pharmaceutical customers to place orders, make payments, design questionnaires, upload brand promotions, and obtain survey results; (5) Security protection module: Encrypts the information collected by the data acquisition module and the large amount of information stored in the data storage module to ensure data security and user privacy.
2. A medical marketing system based on the Taas platform according to claim 1, characterized in that: The user-side display module can also construct a detailed user portrait through data analysis and the information entered by itself.
3. A medical marketing system based on the Taas platform according to claim 2, characterized in that: The data collection module includes a data analysis engine, which uses big data and AI technology to perform in-depth analysis and can provide personalized recommendations to users based on the analysis results.
4. A medical marketing system based on the Taas platform according to claim 3, characterized in that: The personalized recommendation of the data collection module is screened by similarity calculation method, and the similarity calculation formula is Sim = f sim (UP, IP), where Sim in the formula is the similarity score, and f in the formula sim is a similarity calculation function, and the recommendation list generation can be expressed as RL = f rl (Sim,N), where RL in the formula is the recommendation list, f rl is the function that generates the recommendation list, and N is the number of recommended items.
5. A medical marketing system based on the Taas platform according to claim 4, characterized in that: The data storage module also includes data encryption and user authentication. The formula for data encryption is: Enc(Data)=f enc (Data,Key), where Enc(Data) is the encrypted data, f enc Is an encryption function that encrypts data using an encryption algorithm and a key.
6. A medical marketing system based on the Taas platform according to claim 5, characterized in that: The formula for decrypting data in the data storage module is Dec(Enc(Data))=f dex (Enc(Data),Key), where Dec(Enc(Data)) is the decrypted data, i.e. the original data, f dec is the decryption function, which uses the same algorithm and key as the encryption function to decrypt the data.
7. A medical marketing system based on the Taas platform according to claim 6, characterized in that: The formula for user authentication in the data storage module is Auth(User)=f auth (Credentials), where Auth(User) is a Boolean value indicating whether the user is authenticated, fauth is an authentication function that accepts the user's credentials (such as username and password, biometric data, etc.) as input, and Credentials includes the user's identity information.
8. A medical marketing system based on the Taas platform according to claim 7, characterized in that: The user terminal display module includes information architecture design, interaction design and visual design. The formula used in the information architecture design is IAD=f iad (UR), where IAD is information architecture design, which defines the organization and navigation structure of the content, iad It is the information architecture design process.
9. A medical marketing system based on the Taas platform according to claim 8, characterized in that: The interactive design in the user terminal display module adopts ID=f id (IAD), where ID is interaction design, which defines the interaction between users and the system, and f id It is an interactive design process.
10. A medical marketing system based on the Taas platform according to claim 9, characterized in that: The visual design in the user terminal display module adopts VD=f vd (ID), where VD is visual design, including visual elements such as color, font, layout, etc. vd It is a visual design process.